• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 021196 Product 001 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N021196 001 6780889 Jul 4, 2020 Y
N021196 001 7262219 Jul 4, 2020 Y
N021196 001 7668730 Jun 16, 2024 U - 1110
N021196 001 7765106 Jun 16, 2024 U - 1069
N021196 001 7765107 Jun 16, 2024 U - 1070
N021196 001 7851506 Dec 22, 2019 U - 1101
N021196 001 7851506 Dec 22, 2019 U - 1102
N021196 001 7895059 Dec 17, 2022 U - 1110
N021196 001 8263650 Dec 22, 2019 Y U - 1101
N021196 001 8263650 Dec 22, 2019 Y U - 1102
N021196 001 8324275 Dec 22, 2019 U - 1101
N021196 001 8324275 Dec 22, 2019 U - 1102
N021196 001 8457988 Dec 17, 2022 U - 1110
N021196 001 8589182 Dec 17, 2022 U - 1110
N021196 001 8731963 Dec 17, 2022 U - 1110
N021196 001 8772306 Mar 15, 2033 U - 1532

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through August 2014
Patent and Generic Drug Product Data Last Updated September 17, 2014

-
-